555 related articles for article (PubMed ID: 15984315)
1. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
Kochuyt AM; Van Hoeyveld EM; Stevens EA
Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
[TBL] [Abstract][Full Text] [Related]
4. Allergens in hymenoptera venom. IX. Species specificity to Polistes (paper wasp) venoms.
Hoffman DR; McDonald CA
Ann Allergy; 1982 Feb; 48(2):82-6. PubMed ID: 7065471
[TBL] [Abstract][Full Text] [Related]
5. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
Sonneville A; Loustanau O; Tahar HA; Menelet I
Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of hymenoptera venom allergy: comparative study between specific IgE, western blot and allergen leukocyte stimulation (CAST).
Santos MC; Carlos ML; Pedro E; Carlos AG
Allerg Immunol (Paris); 2002 Jan; 34(1):6-9. PubMed ID: 11878133
[TBL] [Abstract][Full Text] [Related]
9. Alternating Polistes-Vespula venom immunotherapy: a therapeutic strategy to resolve a diagnostic deficiency.
Moreno C; Barasona MJ; Serrano P; Justicia JL; Ruz JM; Guerra F
J Investig Allergol Clin Immunol; 2011; 21(1):28-33. PubMed ID: 21370720
[TBL] [Abstract][Full Text] [Related]
10. Suitability of different glycoproteins and test systems for detecting cross-reactive carbohydrate determinant-specific IgE in hymenoptera venom-allergic patients.
Mertens M; Brehler R
Int Arch Allergy Immunol; 2011; 156(1):43-50. PubMed ID: 21447958
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
[TBL] [Abstract][Full Text] [Related]
12. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
13. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic sensitization to hymenoptera venom is related to total immunoglobulin E levels.
Sturm GJ; Schuster C; Kranzelbinder B; Wiednig M; Groselj-Strele A; Aberer W
Int Arch Allergy Immunol; 2009; 148(3):261-4. PubMed ID: 18849617
[TBL] [Abstract][Full Text] [Related]
15. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
[TBL] [Abstract][Full Text] [Related]
16. Natural rubber latex and hymenoptera venoms share ImmunoglobinE-epitopes accounting for cross-reactive carbohydrate determinants.
Mahler V; Gutgesell C; Valenta R; Fuchs T
Clin Exp Allergy; 2006 Nov; 36(11):1446-56. PubMed ID: 17083355
[TBL] [Abstract][Full Text] [Related]
17. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
18. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
19. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition.
Jappe U; Raulf-Heimsoth M; Hoffmann M; Burow G; Hübsch-Müller C; Enk A
Allergy; 2006 Oct; 61(10):1220-9. PubMed ID: 16942573
[TBL] [Abstract][Full Text] [Related]
20. Natural history of Hymenoptera venom allergy in Eastern Spain.
Fernandez J; Soriano V; Mayorga L; Mayor M
Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
